ViiV Healthcare, UNC-Chapel Hill announce five-year, $20 million renewal of HIV cure partnership Read more
AbbVie Partnering with Global Authorities to Determine Efficacy of HIV Drug in Treating COVID-19 Read more
BioCryst Begins Proof of Concept Trial in PNH Patients With Oral Factor D Inhibitor, BCX9930 Read more